What are the major opportunities in the Infectious Disease Molecular Diagnostics market? What are the strategies for the Infectious Disease Molecular Diagnostics market?

For detailed insights on the major opportunities and strategies in the Infectious Disease Molecular Diagnostics market, Read More

How does the Infectious Disease Molecular Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Infectious Disease Molecular Diagnostics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Infectious Disease Molecular Diagnostics market growth? SWOT analysis of the Infectious Disease Molecular Diagnostics market.

For detailed insights on the key dynamics influencing the Infectious Disease Molecular Diagnostics market growth and SWOT analysis of the Infectious Disease Molecular Diagnostics industry, Read More

Infectious Disease Molecular Diagnostics Market Report Infographic Image

Published : April 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Infectious Disease Molecular Diagnostics Market Report 2026

Name: Infectious Disease Molecular Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product Type (Kits And Reagents, Instruments, Software And Services), By Technology (Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies), By Application (Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications), By End-User (Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Infectious Disease Molecular Diagnostics Market Overview

• Infectious Disease Molecular Diagnostics market size has reached to $30.46 billion in 2025

• Expected to grow to $38.77 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%

• Growth Driver: The Rise In Infectious Diseases Propels The Growth Of The Market Due To Global Spread And Need For Rapid Diagnosis

• Market Trend: Innovative Polymerase Chain Reaction Kits Enhance Speed And Accuracy In Detecting Infectious Pathogens

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Infectious Disease Molecular Diagnostics Market?

Infectious disease molecular diagnostics refers to advanced laboratory techniques used to detect and identify genetic material from pathogens such as bacteria, viruses, fungi, or parasites in patient samples. These diagnostics enable rapid and accurate diagnosis of infectious diseases, supporting timely treatment and effective disease management.

The main product types of infectious disease molecular diagnostics are kits and reagents, instruments, software and services. Kits and reagents refer to pre-packaged sets of chemical substances and biological components designed to perform specific laboratory tests or procedures, such as detecting, measuring, or amplifying genetic material, proteins, or pathogens. Key technologies used in this field include polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, chips and microarrays, mass spectrometry, transcription-mediated amplification, and others. These are used for various applications such as respiratory diseases, tuberculosis, meningitis, gastrointestinal tract infections, human papillomavirus, sexually transmitted infections, sepsis, drug-resistant diseases, and others, and utilized by end users such as hospitals and clinical laboratories, diagnostic laboratories, pharmaceutical companies, and academic and research institutes.

Infectious Disease Molecular Diagnostics market report bar graph

What Is The Infectious Disease Molecular Diagnostics Market Size and Share 2026?

The infectious disease molecular diagnostics market size has grown strongly in recent years. It will grow from $30.46 billion in 2025 to $32.04 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to growing prevalence of infectious diseases, advancements in pcr and sequencing technologies, rising government funding for infectious disease research, increasing awareness about early diagnosis, expansion of clinical laboratories.

What Is The Infectious Disease Molecular Diagnostics Market Growth Forecast?

The infectious disease molecular diagnostics market size is expected to see steady growth in the next few years. It will grow to $38.77 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to growing adoption of ai-driven diagnostic tools, rise in demand for rapid and accurate diagnostics, expansion of emerging markets healthcare infrastructure, increasing focus on personalized medicine, growth of home-based molecular diagnostic solutions. Major trends in the forecast period include rapid point-of-care diagnostic adoption, rising demand for multiplex testing, integration of molecular diagnostics with ehr systems, expansion of infectious disease surveillance programs, increasing focus on antimicrobial resistance detection.

Book your 30 minutes free consultation with our research experts

Global Infectious Disease Molecular Diagnostics Market Segmentation

1) By Product Type: Kits And Reagents, Instruments, Software And Services

2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies

3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications

4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits

2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services

What Is The Driver Of The Infectious Disease Molecular Diagnostics Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the infectious disease molecular diagnostics market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can be spread directly or indirectly from one person to another. The rising prevalence of infectious diseases is primarily due to globalization and increased travel, allowing pathogens to spread rapidly across borders and turn localized outbreaks into global health emergencies. Infectious disease molecular diagnostics support infectious disease management by enabling rapid, accurate detection of pathogens at the genetic level, which facilitates early diagnosis, targeted treatment, and effective outbreak control. For instance, in November 2024, according to the US Centers for Disease Control and Prevention (CDC), a US-based government agency, tuberculosis (TB) cases in 2023 reached 9,633, up from 8,332 in 2022 marking a 15.6% increase in case count. Therefore, the increasing prevalence of infectious diseases is driving the growth of the infectious disease molecular diagnostics industry.

Key Players In The Global Infectious Disease Molecular Diagnostics Market

Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.

Global Infectious Disease Molecular Diagnostics Market Trends and Insights

Major companies operating in the infectious disease molecular diagnostics market are focusing on developing innovative solutions, such as real-time polymerase chain reaction kits, to enable rapid, accurate, and high-throughput detection of infectious pathogens. Real-time polymerase chain reaction (PCR) kits are diagnostic tools that amplify and simultaneously detect specific genetic material of pathogens in real time, allowing for rapid and accurate identification of infectious diseases. For instance, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, launched Applied Biosystems TaqPath polymerase chain reaction kits designed for the detection of infectious diseases in India. These kits are fast, highly sensitive multiplex diagnostic solutions that enable real-time polymerase chain reaction detection of infectious disease targets using a complete workflow from ribonucleic acid extraction to diagnostic report generation, typically in under 4 hours. These kits feature multiplexed assays targeting multiple genomic regions of pathogens, include internal process controls, and provide automated data interpretation, reducing user error and enhancing result reliability.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Infectious Disease Molecular Diagnostics Market?

In May 2024, Bruker Corporation, a US-based scientific instrument and analytical technology company, acquired ELITechGroup for $0.94 billion. With this acquisition, Bruker Corporation aims to strengthen its position as a specialist in infectious disease diagnostics by gaining access to modern sample-to-answer molecular diagnostic systems and a broad infectious disease assay portfolio that complements its existing products. ELITechGroup SAS is a France-based company that specializes in infectious disease molecular diagnostics.

Regional Outlook

North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Infectious Disease Molecular Diagnostics Market?

The infectious disease molecular diagnostics market consists of revenues earned by entities by providing services such as polymerase chain Reaction (PCR) testing, next-generation sequencing, isothermal nucleic acid amplification tests, point-of-care (POC) molecular testing, and viral load monitoring and resistance testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease molecular diagnostics market also includes sales of nucleic acid extraction systems, isothermal amplification assays, multiplex diagnostic panels, molecular diagnostic reagents and consumables, and bloodborne pathogen detection kits. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Infectious Disease Molecular Diagnostics Market Report 2026?

The infectious disease molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease molecular diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Infectious Disease Molecular Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$32.04 billion
Revenue Forecast In 2035	$38.77 billion
Growth Rate	CAGR of 5.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Technology, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Infectious Disease Molecular Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Infectious Disease Molecular Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Infectious Disease Molecular Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Infectious Disease Molecular Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rapid Point-Of-Care Diagnostic Adoption

4.2.2 Rising Demand For Multiplex Testing

4.2.3 Integration Of Molecular Diagnostics With Ehr Systems

4.2.4 Expansion Of Infectious Disease Surveillance Programs

4.2.5 Increasing Focus On Antimicrobial Resistance Detection

5. Infectious Disease Molecular Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals And Clinical Laboratories

5.2 Diagnostic Laboratories

5.3 Pharmaceutical Companies

5.4 Academic And Research Institutes

5.5 Public Health Organizations

6. Infectious Disease Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Infectious Disease Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Infectious Disease Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Infectious Disease Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Infectious Disease Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Infectious Disease Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Infectious Disease Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Infectious Disease Molecular Diagnostics Market Segmentation

9.1. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Kits And Reagents, Instruments, Software And Services

9.2. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies

9.3. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications

9.4. Global Infectious Disease Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes

9.5. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits

9.6. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers

9.7. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services

10. Infectious Disease Molecular Diagnostics Market Regional And Country Analysis

10.1. Global Infectious Disease Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Infectious Disease Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Infectious Disease Molecular Diagnostics Market

11.1. Asia-Pacific Infectious Disease Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Infectious Disease Molecular Diagnostics Market

12.1. China Infectious Disease Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Infectious Disease Molecular Diagnostics Market

13.1. India Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Infectious Disease Molecular Diagnostics Market

14.1. Japan Infectious Disease Molecular Diagnostics Market Overview

14.2. Japan Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Infectious Disease Molecular Diagnostics Market

15.1. Australia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Infectious Disease Molecular Diagnostics Market

16.1. Indonesia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Infectious Disease Molecular Diagnostics Market

17.1. South Korea Infectious Disease Molecular Diagnostics Market Overview

17.2. South Korea Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Infectious Disease Molecular Diagnostics Market

18.1. Taiwan Infectious Disease Molecular Diagnostics Market Overview

18.2. Taiwan Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Infectious Disease Molecular Diagnostics Market

19.1. South East Asia Infectious Disease Molecular Diagnostics Market Overview

19.2. South East Asia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Infectious Disease Molecular Diagnostics Market

20.1. Western Europe Infectious Disease Molecular Diagnostics Market Overview

20.2. Western Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Infectious Disease Molecular Diagnostics Market

21.1. UK Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Infectious Disease Molecular Diagnostics Market

22.1. Germany Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Infectious Disease Molecular Diagnostics Market

23.1. France Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Infectious Disease Molecular Diagnostics Market

24.1. Italy Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Infectious Disease Molecular Diagnostics Market

25.1. Spain Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Infectious Disease Molecular Diagnostics Market

26.1. Eastern Europe Infectious Disease Molecular Diagnostics Market Overview

26.2. Eastern Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Infectious Disease Molecular Diagnostics Market

27.1. Russia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Infectious Disease Molecular Diagnostics Market

28.1. North America Infectious Disease Molecular Diagnostics Market Overview

28.2. North America Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Infectious Disease Molecular Diagnostics Market

29.1. USA Infectious Disease Molecular Diagnostics Market Overview

29.2. USA Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Infectious Disease Molecular Diagnostics Market

30.1. Canada Infectious Disease Molecular Diagnostics Market Overview

30.2. Canada Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Infectious Disease Molecular Diagnostics Market

31.1. South America Infectious Disease Molecular Diagnostics Market Overview

31.2. South America Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Infectious Disease Molecular Diagnostics Market

32.1. Brazil Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Infectious Disease Molecular Diagnostics Market

33.1. Middle East Infectious Disease Molecular Diagnostics Market Overview

33.2. Middle East Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Infectious Disease Molecular Diagnostics Market

34.1. Africa Infectious Disease Molecular Diagnostics Market Overview

34.2. Africa Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Infectious Disease Molecular Diagnostics Market Regulatory and Investment Landscape

36. Infectious Disease Molecular Diagnostics Market Competitive Landscape And Company Profiles

36.1. Infectious Disease Molecular Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Infectious Disease Molecular Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Infectious Disease Molecular Diagnostics Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Infectious Disease Molecular Diagnostics Market Other Major And Innovative Companies

Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.

38. Global Infectious Disease Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Infectious Disease Molecular Diagnostics Market

40. Infectious Disease Molecular Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Infectious Disease Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Infectious Disease Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Infectious Disease Molecular Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Infectious Disease Molecular Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Infectious Disease Molecular Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Infectious Disease Molecular Diagnostics Market, Supply Chain Analysis

Table 4: Global Infectious Disease Molecular Diagnostics Market, Major Raw Material Providers

Table 5: Global Infectious Disease Molecular Diagnostics Market, Major Resource Providers

Table 6: Global Infectious Disease Molecular Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Infectious Disease Molecular Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Infectious Disease Molecular Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Infectious Disease Molecular Diagnostics Market, Major Trends

Table 10: Global Infectious Disease Molecular Diagnostics Market, Major End Users

Table 11: Global Infectious Disease Molecular Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Infectious Disease Molecular Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Infectious Disease Molecular Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Infectious Disease Molecular Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Infectious Disease Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Infectious Disease Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Infectious Disease Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Infectious Disease Molecular Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Infectious Disease Molecular Diagnostics Market - Company Scoring Matrix

Table 98: F. Hoffmann-La Roche Ltd Financial Performance

Table 99: Thermo Fisher Scientific Inc. Financial Performance

Table 100: Abbott Laboratories Financial Performance

Table 101: Danaher Corporation Financial Performance

Table 102: Siemens Healthineers AG Financial Performance

Table 103: Global Infectious Disease Molecular Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Infectious Disease Molecular Diagnostics Market, Competitive Dashboard

Table 105: Global Infectious Disease Molecular Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Infectious Disease Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 107: Global, Infectious Disease Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 108: Global, Infectious Disease Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Infectious Disease Molecular Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Infectious Disease Molecular Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Infectious Disease Molecular Diagnostics Market, Supply Chain Analysis

Figure 4: Global Infectious Disease Molecular Diagnostics Market, Major Raw Material Providers

Figure 5: Global Infectious Disease Molecular Diagnostics Market, Major Resource Providers

Figure 6: Global Infectious Disease Molecular Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Infectious Disease Molecular Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Infectious Disease Molecular Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Infectious Disease Molecular Diagnostics Market, Major Trends

Figure 10: Global Infectious Disease Molecular Diagnostics Market, Major End Users

Figure 11: Global Infectious Disease Molecular Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Infectious Disease Molecular Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Infectious Disease Molecular Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Infectious Disease Molecular Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Infectious Disease Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Infectious Disease Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Infectious Disease Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Infectious Disease Molecular Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Infectious Disease Molecular Diagnostics Market - Company Scoring Matrix

Figure 98: F. Hoffmann-La Roche Ltd Financial Performance

Figure 99: Thermo Fisher Scientific Inc. Financial Performance

Figure 100: Abbott Laboratories Financial Performance

Figure 101: Danaher Corporation Financial Performance

Figure 102: Siemens Healthineers AG Financial Performance

Figure 103: Global Infectious Disease Molecular Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Infectious Disease Molecular Diagnostics Market, Competitive Dashboard

Figure 105: Global Infectious Disease Molecular Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Infectious Disease Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 107: Global, Infectious Disease Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 108: Global, Infectious Disease Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Latest Market Developments in Aseptic Connectors And Welders Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Atrial Fibrillation Devices Industry Through 2029

Industry Trends Show Bioabsorbable Surgical Mesh Market Set to Expand at 8.6% CAGR Until 2029

Strategic Report on Biodegradable Hemostat Market: Growth Opportunities and Emerging Challenges

Point-Of-Care Molecular Diagnostics Market Report 2026 - Global Outlook – By Product (Assays And Kits, Instruments And Analyzers), By Application (Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted...

DNA Diagnostics Market Report 2026 - Global Outlook – By Product Type (Instruments, Reagents, Software And Services), By Technology (Polymerase Chain Reaction, Microarray, In-situ Hybridization, Sequencing Technology, Ma...

Veterinary Infectious Disease Diagnostics Market Report 2026 - Global Outlook – By Infection Type (Viral Infections, Bacterial Infections, Parasitic Infections, Other Infections), By Animal Type (Companion Animal, Food-P...

Clinical Diagnostics Market Report 2026 - Global Outlook – By Test (Lab Test, Imaging Test, Other Tests), By Product (Instruments, Reagents, Other Products ), By End User (Hospital Laboratory, Diagnostic Laboratory, Poin...

Viral Diagnostic Test Kits Market Report 2026 - Global Outlook – By Testing Approach (Traditional Tests, Rapid Test), By Test Type (Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcripta...

Molecular Diagnostics Devices And Equipment Market Report 2026 - Global Outlook – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA(Deoxyribonucleic acid) sequencing, Polymerase chain react...

Rare Disease Diagnostics Market Report 2026 - Global Outlook – By Test Type (Genetic Test, General Lab Test, Imaging Test), By Technology (Capillary Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarray...

Frequently Asked Questions

How big is the Infectious Disease Molecular Diagnostics Market?

The Infectious Disease Molecular Diagnostics market was valued at $30.46 billion in 2025, increased to $32.04 billion in 2026, and is projected to reach $38.77 billion by 2030.

What is the Infectious Disease Molecular Diagnostics market growth?

The global Infectious Disease Molecular Diagnostics market is expected to grow at a CAGR of 4.9% from 2026 to 2035 to reach $38.77 billion by 2035.

Who are the key players in Infectious Disease Molecular Diagnostics market?

Some Key Players in the Infectious Disease Molecular Diagnostics market Include, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel‑Ortho Corporation, Sysmex Corporation, Bio‑Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc. .

What is the anticipated growth trend for the Infectious Disease Molecular Diagnostics market?

Major trend in this market includes: Innovative Polymerase Chain Reaction Kits Enhance Speed And Accuracy In Detecting Infectious Pathogens. For further insights on this market. request a sample here

Which region has the most growth potential in the Infectious Disease Molecular Diagnostics market?

North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.